Clinical Cancer Research Grants AACR Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Potter, K. N.
Right arrow Articles by Stevenson, F. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Potter, K. N.
Right arrow Articles by Stevenson, F. K.
Clinical Cancer Research Vol. 12, 1672-1679, March 2006
© 2006 American Association for Cancer Research


Human Cancer Biology

Structural and Functional Features of the B-Cell Receptor in IgG-Positive Chronic Lymphocytic Leukemia

Kathleen N. Potter1, C. Ian Mockridge1, Louise Neville1, Isla Wheatley1, Michael Schenk1, Jennifer Orchard4, Andrew S. Duncombe2, Graham Packham3 and Freda K. Stevenson1

Authors' Affiliations: 1 Molecular Immunology Group, Tenovus Research Laboratory, Cancer Sciences Division, Southampton General Hospital; 2 Department of Haematology, Southampton University Hospitals Trust; 3 Cancer Research UK Clinical Centre, Southampton, United Kingdom; and 4 Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom

Requests for reprints: Kathleen N. Potter, Cancer Sciences Division, Southampton General Hospital, Somers Cancer Research Building, Mailpont 891, Tremona Road, Southampton SO16 6YD, United Kingdom. E-mail: kp1{at}soton.ac.uk.

Purpose: To determine the origin and relationship of the rare IgG+ variant of chronic lymphocytic leukemia (CLL) to the two common IgM+IgD+ subsets that are distinguished by expression of unmutated or mutated VH genes, with the former having a worse prognosis.

Experimental Design: IgG+ CLL cells were characterized using phenotypic, functional, and immunogenetic analyses.

Results: IgG+ CLL was phenotypically similar to mutated IgM+IgD+ CLL (M-CLL) and variably expressed CD38 (4 of 14). ZAP-70, a tyrosine kinase preferentially expressed in unmutated CLL, was found in only 2 of 14 cases. The ability to signal via surface IgM (sIgM) varies between the main subsets of CLL and is associated with expression of ZAP-70. In IgG+ CLL, 9 of 14 responded to engagement of sIgG with no apparent requirement for expression of CD38 or ZAP-70. However, signal capacity correlated with intensity of sIgG expression. Most switched immunoglobulin variable region genes were somatically mutated without intraclonal variation, and no case expressed activation-induced cytidine deaminase. Derivation from a postgerminal center B cell is, therefore, likely, and a relationship with M-CLL is suggested. This is supported by a shared biased usage of the V4-34 gene. Similar bias in normal B cells developed with age, providing an expanded population for transforming events. However, conserved sequences detected in the CDR3 of V4-34-encoded {gamma} chains were not found M-CLL, indicating no direct path of isotype switch from M-CLL.

Conclusion: IgG+ CLL is likely to arise from an age-related expanded pool of B cells, on a path parallel to M-CLL, and perhaps with a similar clinical course.




This article has been cited by other articles:


Home page
haematolHome page
A. Athanasiadou, K. Stamatopoulos, M. Gaitatzi, N. Stavroyianni, A. Fassas, and A. Anagnostopoulos
Recurrent cytogenetic findings in subsets of patients with chronic lymphocytic leukemia expressing IgG-switched stereotyped immunoglobulins
Haematologica, March 1, 2008; 93(3): 473 - 474.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Murray, N. Darzentas, A. Hadzidimitriou, G. Tobin, M. Boudjogra, C. Scielzo, N. Laoutaris, K. Karlsson, F. Baran-Marzsak, A. Tsaftaris, et al.
Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis
Blood, February 1, 2008; 111(3): 1524 - 1533.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Ian Mockridge, K. N. Potter, I. Wheatley, L. A. Neville, G. Packham, and F. K. Stevenson
Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status
Blood, May 15, 2007; 109(10): 4424 - 4431.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.